Please login to the form below

F2G

This page shows the latest F2G news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s John Rex joins UK biotech F2G

John Rex has moved from AstraZeneca to F2G to become the Manchester, UK-based drug discovery firm's chief medical officer. ... new role Rex will be tasked with helping move F2G's first-in-class antifungal F901218 through phase II clinical trials.
F2G appoints chief financial officer

Ralf Schmid brings experience from Nabriva Therapeutics. Manchester-based F2G Ltd has appointed Ralf Schmid as its new chief financial officer. ... Ian Nicholson, chief executive of F2G, said: “Following our successful $60m financing, I am delighted to

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Add my company

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Reaching patients and HCPs during the pandemic: COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]: Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
Looking back at the year when everything changed: COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families....